CS Diagnostics Corp. (CSDX)

OTCMKTS · Delayed Price · Currency is USD
0.185
+0.035 (23.33%)
At close: Feb 27, 2026
-65.09%
Market Cap 46.25M
Revenue (ttm) 98.73K
Net Income (ttm) 19.39K
Shares Out 249.99M
EPS (ttm) 0.00
PE Ratio 2,384.68
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 12,650
Average Volume 41,313
Open 0.150
Previous Close 0.150
Day's Range 0.150 - 0.190
52-Week Range 0.036 - 0.550
Beta -23.92
RSI 43.42
Earnings Date May 13, 2026

About CS Diagnostics

CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant product; and CS-Protect Hydrogel, a tissue spacer gel for use in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Neuss, Germany. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1996
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol CSDX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.